ID

33286

Beskrivning

Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains the Electronically transferred laboratory data form (Clinial chemistry, haematology, urinanalysis). It has to be filled in for sceening, study visit and follow up. If the laboratory results meet the protocol definition of an adverse event, record the details in the Non-Serious Adverse Events or Serious Adverse Event section(s).

Länk

https://clinicaltrials.gov/ct2/show/NCT00599612

Nyckelord

Versioner (1)

1. 2018-12-04 2018-12-04 -

Rättsinnehavare

GlaxoSmithKline

Uppladdad den

4 december 2018

DOI

För en begäran logga in.

Licens